Infarction Cerebral Completed Phase 3 Trials for Cilostazol (DB01166)

Also known as: Cerebral Infarct / Cerebral Infarction / Cerebral Infarctions / Cerebral infarction, unspecified / Cerebral infarction (disorder) / Infarct cerebral / Occlusion of cerebral arteries / Occlusion of cerebral artery (disorder) / Cerebral artery occlusion, unspecified / Cerebral artery occlusion

IndicationStatusPhase
DBCOND0158720 (Infarction Cerebral)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00766545Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.Prevention
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokePrevention